The degree of cognitive dysfunction in AD patients is significantly correlated with decline in ChAT activity and loss of cholinergic neurons, while AChE acts to degrade ACh to acetate and choline in the synaptic cleft and eventually terminates cholinergic transmission [47]. The gene discussed is ACHE; the disease is Alzheimer disease.